IDOGEN.ST
Price:
$0.1205
Market Cap:
$12.79M
Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment with coagulation factor VIII. It also develops IDO T, a tolerogenic cell therapy to prevent organ transplant rejection primarily kidney transplantation; and IDO AID for the treatment of autoimmune diseases. The company was incorporated in 2008 and is headquartered in Lund, Sweden.
Industry
Biotechnology
IPO Date
2015-06-12
Stock Exchange
STO
Ticker
IDOGEN.ST
According to Idogen AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -0.32. This represents a change of -6.97% compared to the average of -0.34 of the last 4 quarters.
The mean historical PE Ratio of Idogen AB (publ) over the last ten years is -7.63. The current -0.32 PE Ratio has changed 315.60% with respect to the historical average. Over the past ten years (40 quarters), IDOGEN.ST's PE Ratio was at its highest in in the December 2022 quarter at -0.24. The PE Ratio was at its lowest in in the September 2014 quarter at -150.67.
Average
-7.63
Median
-1.74
Minimum
-40.13
Maximum
-0.23
Discovering the peaks and valleys of Idogen AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 81.16%
Maximum Annual PE Ratio = -0.23
Minimum Annual Increase = -82.20%
Minimum Annual PE Ratio = -40.13
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.23 | -64.84% |
| 2021 | -0.66 | -39.88% |
| 2020 | -1.09 | -15.05% |
| 2019 | -1.28 | -26.20% |
| 2018 | -1.74 | -49.70% |
| 2017 | -3.46 | -73.27% |
| 2016 | -12.94 | 81.16% |
| 2015 | -7.14 | -82.20% |
The current PE Ratio of Idogen AB (publ) (IDOGEN.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.66
5-year avg
-1.00
10-year avg
-7.63
Idogen AB (publ)’s PE Ratio is greater than Pharmiva AB (publ) (-0.41), greater than Amniotics AB (publ) (-0.49), less than Ziccum AB (publ) (-0.29), less than Learning 2 Sleep L2S AB (publ) (-0.02), greater than Diagonal Bio AB (publ) (-2.16), less than Pharmacolog i Uppsala AB (publ) (-0.09), greater than VibroSense Dynamics AB (-1.58), greater than AegirBio AB (publ) (-0.71), less than Cyxone AB (publ) (-0.08), greater than Pexa AB (-2.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.41 | $12.93M | |
| -0.49 | $14.76M | |
| -0.29 | $8.56M | |
| -0.02 | $11.68M | |
| -2.16 | $20.20M | |
| -0.09 | $10.70M | |
| -1.58 | $12.70M | |
| -0.71 | $15.43M | |
| -0.08 | $6.75M | |
| -2.21 | $10.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Idogen AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Idogen AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Idogen AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Idogen AB (publ) (IDOGEN.ST)?
What is the highest PE Ratio for Idogen AB (publ) (IDOGEN.ST)?
What is the 3-year average PE Ratio for Idogen AB (publ) (IDOGEN.ST)?
What is the 5-year average PE Ratio for Idogen AB (publ) (IDOGEN.ST)?
How does the current PE Ratio for Idogen AB (publ) (IDOGEN.ST) compare to its historical average?